Literature DB >> 29599226

Natural killers join the fight against cancer.

Adelheid Cerwenka1, Lewis L Lanier2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29599226     DOI： 10.1126/science.aat2184

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  13 in total

1.  KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.

Authors:  Matthew D Blunt; Andres Vallejo Pulido; Jack G Fisher; Lara V Graham; Amber D P Doyle; Rebecca Fulton; Matthew J Carter; Marta Polak; Peter W M Johnson; Mark S Cragg; Francesco Forconi; Salim I Khakoo
Journal:  J Immunol       Date:  2022-06-29       Impact factor: 5.426

2.  A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma.

Authors:  Hao Zhou; Chang Zheng; De-Sheng Huang
Journal:  PeerJ       Date:  2020-08-05       Impact factor: 2.984

3.  Therapeutic ISCOMATRIX™ adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer.

Authors:  Adele M Barr; Anabel Silva; Sandro Prato; Gabrielle T Belz; Eugene Maraskovsky; Adriana Baz Morelli
Journal:  Cancer Immunol Immunother       Date:  2020-05-09       Impact factor: 6.968

Review 4.  Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

Authors:  Pascale André; Caroline Denis; Caroline Soulas; Clarisse Bourbon-Caillet; Julie Lopez; Thomas Arnoux; Mathieu Bléry; Cécile Bonnafous; Laurent Gauthier; Ariane Morel; Benjamin Rossi; Romain Remark; Violette Breso; Elodie Bonnet; Guillaume Habif; Sophie Guia; Ana Ines Lalanne; Caroline Hoffmann; Olivier Lantz; Jérôme Fayette; Agnès Boyer-Chammard; Robert Zerbib; Pierre Dodion; Hormas Ghadially; Maria Jure-Kunkel; Yannis Morel; Ronald Herbst; Emilie Narni-Mancinelli; Roger B Cohen; Eric Vivier
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

Review 5.  Therapeutic Potential of Natural Killer Cells in Gastric Cancer.

Authors:  Yu Du; Yongchang Wei
Journal:  Front Immunol       Date:  2019-01-21       Impact factor: 7.561

Review 6.  The Role of Natural Killer Cells in Autoimmune Diseases.

Authors:  Umut Can Kucuksezer; Esin Aktas Cetin; Fehim Esen; Ilhan Tahrali; Nilgun Akdeniz; Metin Yusuf Gelmez; Gunnur Deniz
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

7.  Identification and Validation of the lncRNA BACE1-AS as Immune-Related Influencing Factor in Tumorigenesis following Pan-Carcinoma Analysis.

Authors:  Mengmeng Wang; Di Chen; Yushuang Xu; Mengjun Qiu; Xin Jiang; Zhifan Xiong
Journal:  J Immunol Res       Date:  2021-12-08       Impact factor: 4.818

8.  Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture.

Authors:  Jan P Bogen; Stefania C Carrara; David Fiebig; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

9.  BCL11B regulates MICA/B-mediated immune response by acting as a competitive endogenous RNA.

Authors:  Mengyao Qian; Jingwen Geng; Kaili Luo; Zheng Huang; Qinkai Zhang; Jian-An Zhang; Liying Ji; Jianmin Wu
Journal:  Oncogene       Date:  2019-10-31       Impact factor: 8.756

Review 10.  Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28.

Authors:  F R Mariotti; L Quatrini; E Munari; P Vacca; N Tumino; G Pietra; M C Mingari; L Moretta
Journal:  Br J Pharmacol       Date:  2020-05-18       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.